A preliminary comparison of levalbuterol and albuterol in prehospital care

Journal of Emergency Medicine

Volumn 26, Issue 3, 2004, Pages 271-277

  Thompson, Monica ^a   Wise, Suzanne ^a   Rodenberg, Howard ^b,c  

^a EMBRY RIDDLE AERONAUTICAL UNIVERSITY   (United States)

^b Advanced Medical Direction   (United States)

^c C/o Advanced Medical Direction ^*  (United States)

Author keywords

Albuterol; Asthma; COPD; Emergency; EMS; Levalbuterol; Respiratory

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; LEVALBUTEROL; SALBUTAMOL;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; BRONCHIAL SPASM; BRONCHODILATOR AGENTS; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PULMONARY VENTILATION; TREATMENT OUTCOME;

EID: 1542718640     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2003.11.019     Document Type: Article

References (21)

1. Handley D.A., Morley J. The pursuit of precision pharmaceuticals divergent effects of beta-2 agonist isomers. Expert Opin Investig Drugs. 7:1998;1601-1616.
2. Penn R.B., Frielle T., McCullough J.R., Aberg G., Benovic J.L. Comparison of R-, S-, and R,S-albuterol interaction with human beta 1- and beta 2-adrenergic receptors. Clin Rev Allergy Immunol. 14:1996;37-45.
3. Koch P., McCullough F.R., DeGraw S.S., Rubin P.D. Pharamcokinetics and safety of (R), (S), and (R,S) albuterol following nebulization in healthy volunteers. Am J Respir Crit Care Med. 155:1997;A279.
4. Nowak R. Single-isomer levalbuterol a review of the acute data. Curr Allergy Asthma Rep. 3:2003;172-178.
5. Yamaguchi H., McCullough J.R. S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clin Rev Allergy Immunol. 14:1996;47-55.
6. Mitra S., Ugur M., Ugur O., Goodman H.M., McCollough J.R., Yamaguchi H. S-albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol. 53:1998;347-354.
7. Templeton A.G.B., Chapman I.D., Chilvers E.R., Morley J., Handley D.A. Effects of S- salbutamol on human isolated bronchus. Pulm Pharmacol Ther. 11:1998;1-6.
8. Volcheck G.W., Gleich G.J., Mita H. Pro- and anti-inflammatory effects of beta adrenergic agonists on eosinophil response to IL-5. J Allergy Clin Immunol. 101:1998;S35.
9. Schwartz Y., Tarantino P., Jerussi T. R- and S-albuterol exhibit differential effects on mucociliary transport velocity. Chest. 122:2002;188S.
10. Perrin-Fayolle M., Blum P.S., Morley J., Grosclaude M., Chambe M.T. Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma. Clin Rev Allergy Immunol. 14:1996;139-147.
11. Nelson H.S., Bensch G., Pleskow W.W., et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol. 102:1998;943-952.
12. Gawchik S.M., Saccar C.L., Noonan M., Reasner D.S., DeGraw S.S. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol. 103:1999;615-621.
13. Nowak R.M., Emerman C.L. Levalbuterol is effective in acute asthma. Am J Respir Critl Care Med. 163:2001;A473.
14. Haider D. Levalbuterol affords superior health and cost benefit over racemic albuterol in the emergency department. Respir Care. 46:2001;1081.
15. Schreck D.M., Brotea C., Shah S.P. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma. Ann Emerg Med. 38:2001;S10.
16. Carl J.C., Myers T., Kercsmar C.M. Comparison of levalbuterol and racemic albuterol for treatment of acute asthma in pediatric patients. Chest. 120:2001;137S.
17. Truitt T., Witko J., Halpern M. Levalbuterol compared to racemic albuterol efficacy and outcomes in patients hospitalized with COPD or asthma. Chest. 123:2003;128-135.
18. Rodenberg H. Effect of levalbuterol on prehospital patient parameters. Am J Emerg Med. 20:2002;481-483.
19. Emerman C.L., Nowak R.M. Inverse correlation between S-albuterol levels and FEV1 in the emergency department. Acad Emerg Med. 9:2002;404.
20. rd edn. 1995;Oxford University Press, New York.
21. Kelsey J.L., Petitti D.B., King A.C. Key methodologic concepts and issues. Brownson R.C., Petitti D.B. Applied epidemiology: theory to practice. 1998;54-57 Oxford University Press, New York.